His primary areas of study are Neuroscience, Amyotrophic lateral sclerosis, Transcranial magnetic stimulation, Internal medicine and Frontotemporal dementia. His research brings together the fields of Depolarization and Neuroscience. His study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Neuromuscular disease and Neurodegeneration.
The various areas that Matthew C. Kiernan examines in his Transcranial magnetic stimulation study include Evoked potential, Compound muscle action potential, Inhibitory postsynaptic potential and Degenerative disease. The Internal medicine study combines topics in areas such as Peripheral neuropathy, Endocrinology, Surgery, Oncology and Cardiology. His Frontotemporal dementia study also includes fields such as
His primary scientific interests are in Amyotrophic lateral sclerosis, Neuroscience, Internal medicine, Disease and Transcranial magnetic stimulation. His Amyotrophic lateral sclerosis research integrates issues from Cognition, Pathophysiology, Physical medicine and rehabilitation and Frontotemporal dementia. His work deals with themes such as Neurodegeneration and Depolarization, which intersect with Neuroscience.
His research investigates the link between Internal medicine and topics such as Peripheral neuropathy that cross with problems in Kidney disease. Matthew C. Kiernan combines subjects such as Clinical trial and Intensive care medicine with his study of Disease. His Transcranial magnetic stimulation research is multidisciplinary, incorporating perspectives in Motor cortex, Threshold tracking and Evoked potential.
His primary areas of investigation include Amyotrophic lateral sclerosis, Internal medicine, Disease, Neuroscience and Frontotemporal dementia. His study in Amyotrophic lateral sclerosis is interdisciplinary in nature, drawing from both Disease progression, Genetics, Clinical trial, Transcranial magnetic stimulation and Cognition. His work carried out in the field of Internal medicine brings together such families of science as Peripheral neuropathy, Oncology and Cardiology.
While the research belongs to areas of Disease, he spends his time largely on the problem of Intensive care medicine, intersecting his research to questions surrounding MEDLINE. His research in Neuroscience intersects with topics in Neuroinflammation and Neurodegeneration. The study incorporates disciplines such as Endocrinology, Putamen, Pathological and Atrophy in addition to Frontotemporal dementia.
Matthew C. Kiernan mostly deals with Amyotrophic lateral sclerosis, Internal medicine, Neuroscience, Frontotemporal dementia and Disease. His Amyotrophic lateral sclerosis research includes themes of Transcranial magnetic stimulation, Clinical trial, Disease progression and Intensive care medicine. His research integrates issues of Endocrinology and Cardiology in his study of Internal medicine.
His Neuroscience research incorporates elements of Neuroinflammation, Nerve membrane, Neurodegeneration and Dementia. His studies deal with areas such as Pathological, Neuropsychology, Proteomics, Putamen and Atrophy as well as Frontotemporal dementia. His Disease study combines topics from a wide range of disciplines, such as Precision medicine, Immunology, Blood proteins, S100A8 and Calcium ion binding.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical diagnosis and management of amyotrophic lateral sclerosis
Orla Hardiman;Leonard H. van den Berg;Matthew C. Kiernan.
Nature Reviews Neurology (2011)
Chemotherapy-induced peripheral neurotoxicity: a critical analysis.
Susanna B. Park;David Goldstein;Arun V. Krishnan;Cindy S-Y Lin.
CA: A Cancer Journal for Clinicians (2013)
Controversies and priorities in amyotrophic lateral sclerosis
Martin R Turner;Orla Hardiman;Michael Benatar;Benjamin R Brooks.
Lancet Neurology (2013)
Biomarkers in amyotrophic lateral sclerosis.
Martin R Turner;Matthew C Kiernan;P Nigel Leigh;Kevin Talbot.
Lancet Neurology (2009)
Multiple measures of axonal excitability: A new approach in clinical testing
Matthew C. Kiernan;David Burke;Kjeld V. Andersen;Hugh Bostock.
Muscle & Nerve (2000)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin.
Nature Genetics (2016)
Excitability of human axons.
D Burke;MC Kiernan;H Bostock.
Clinical Neurophysiology (2001)
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Steve Vucic;Garth A. Nicholson;Matthew C. Kiernan.
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi.
Guillain-Barré syndrome: an update.
Steve Vucic;Matthew C. Kiernan;David R. Cornblath.
Journal of Clinical Neuroscience (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: